FDA clears device for prolonged ECMO, another for faster deployment

Abbott announced FDA clearances for two components of the company’s life support system.
The CentriMag blood pump is now indicated for use with the CentriMag system for longer-term use in adults requiring extracorporeal membrane oxygenation (ECMO), allowing more time to assess next steps in the care for critically ill patients, according to a company release.
The pump is now cleared for providing longer-term life support for more than 6 hours through ECMO.
The company also received FDA clearance for its new prepackaged system with several pre-connected components that could accelerate the

Abbott announced FDA clearances for two components of the company’s life support system.
The CentriMag blood pump is now indicated for use with the CentriMag system for longer-term use in adults requiring extracorporeal membrane oxygenation (ECMO), allowing more time to assess next steps in the care for critically ill patients, according to a company release.
The pump is now cleared for providing longer-term life support for more than 6 hours through ECMO.
The company also received FDA clearance for its new prepackaged system with several pre-connected components that could accelerate the